1-3 of 3
Carolyn Goldman
Close
Sort by
Journal Articles

Yttrium-90 Radiolabeled Daclizumab, An Anti-CD25 Monoclonal Antibody, Provides Effective Therapy for Refractory and Relapsed Hodgkin's Lymphoma,

Thomas A. Waldmann, MD, John Janik, MD, John C Morris, Kevin Conlon, Deirdre O'Mahony, MB, BCh, BAO, MRCP(UK), MSc, Stefania Pittaluga, Elaine S. Jaffe, MD, Martin Brechbiel, Chang H Paik, Clara Chen, Millie Whatley, CNMT, Thomas A Fleisher, Jeffrey White, MD, Donn Stewart, Suzanne Fioravanti, Carolyn Goldman, Bonita Bryant, Jean Decker, Richard Junghans, Jorge A. Carrasquillo, MD
Journal: Blood
Blood (2011) 118 (21): 3706.
https://doi.org/10.1182/blood.V118.21.3706.3706
Published: 2011
Journal Articles

Effective treatment of a murine model of adult T-cell leukemia using 211 At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25

Zhuo Zhang, Meili Zhang, Kayhan Garmestani, Vladimir S. Talanov, Paul S. Plascjak, Barbara Beck, Carolyn Goldman, Martin W. Brechbiel, Thomas A. Waldmann
Journal: Blood
Blood (2006) 108 (3): 1007–1012.
https://doi.org/10.1182/blood-2005-11-4757
Published: 2006
Journal Articles

Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507

Zhuo Zhang, Meili Zhang, Jeffrey V. Ravetch, Carolyn Goldman, Thomas A. Waldmann
Journal: Blood
Blood (2003) 102 (1): 284–288.
https://doi.org/10.1182/blood-2002-11-3601
Published: 2003